Zacks Investment Research on MSN
SLN stock skyrockets 107% in six months: Here's what you need to know
Shares of Silence Therapeutics SLN have surged 107% over the past six months, driven by investor optimism around the ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Silence Therapeutics PLC Sponsored ADR (SLN) shares soared 7.2% in the last trading session to close at $10.45. The move was ...
Silence Therapeutics PLC Sponsored ADR (SLN) shares soared 5.7% in the last trading session to close at $22.36. The move was backed by solid volume with far more shares changing hands than in a normal ...
Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results